Skip to main content

Anti-obesity Drugs

  • Living reference work entry
  • First Online:
Encyclopedia of Molecular Pharmacology
  • 190 Accesses

Synonyms

Weight-loss therapies; Weight-management pharmacotherapy

Definition

Obesity is characterized by the accumulation of body fat resulting from excess energy intake over energy expenditure for a prolonged period of time. A commonly used assessment to define obesity is the body mass index (BMI), measured as a person’s body weight in kilograms divided by the squared height in meters (kg/m2). Obesity is defined by a BMI of ≥30 kg/m2, and overweight is defined by a BMI of 25–29.9 kg/m2. Obesity increases the risk for comorbidities such as type 2 diabetes and cardiovascular disease. Treatment with anti-obesity drugs is recommended for obese patients with BMI ≥30 kg/m2 or BMI ≥27 kg/m2with existing comorbidities and aims to reduce body weight by ≥5%, an effect that was shown to be beneficial for reducing comorbidities and high glucose or high triglyceride profiles. The anti-obesity drugs currently approved for long-term weight management act primarily as appetite suppressants on the...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Andrew CA, Saunders K, Shukla AP, Aronne LJ (2019) Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options. Expert Opin Pharmacother 20(5):585–593

    Article  CAS  Google Scholar 

  • Bray GA, Heisel WE, Afshin A et al (2018) The science of obesity management: an endocrine society scientific statement. Endocr Rev 39:79–132

    Article  Google Scholar 

  • Müller TD, Clemmensen C, Finan B, DiMarchi RD, Tschöp MH (2018) Anti-obesity therapy: from rainbow pills to polyagonists. Pharmacol Rev 70:712–746

    Article  Google Scholar 

  • Patel D (2015) Pharmacotherapy for the management of obesity. Metabolism 64(11):1376–1385

    Article  CAS  Google Scholar 

  • World Health Organization (2018) Obesity and overweight. World Health Organization, Geneva. Available online: http://www.who.int/mediacentre/factsheets/fs311/en/

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christine Huppertz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag Berlin Heidelberg New York

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Huppertz, C. (2020). Anti-obesity Drugs. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-21573-6_167-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21573-6_167-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21573-6

  • Online ISBN: 978-3-030-21573-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics